ClinicalTrials.Veeva

Menu
F

FAX Pharma Clinical Research | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ESK-001
Dupilumab
Upadacitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Enrolling
Atopic Dermatitis
Drug: Upadacitinib 30mg Dose
Drug: Upadacitinib 15mg Dose

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Active, not recruiting
Psoriasis
Severe Psoriasis
Drug: Open-Label Envudeucitinib
Drug: Blinded Envudeucitinib

Trial sponsors

A
AbbVie logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems